Back
FinVolution Group Vs. Verona Pharma PLC Industry Stock Comparison
Buy
65
FINV
FinVolution Group
Last Price:
$6.92
Seasonality Move:
29.14%
Sell
48
VRNA
Verona Pharma PLC
Last Price:
$45.02
Seasonality Move:
1.28%
Buy
65
FinVolution Group (FINV)
is a Buy
Is FinVolution Group a Buy, Sell or Hold?
-
The current FinVolution Group [FINV] share price is $6.87. The Score for FINV is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
FINV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Verona Pharma PLC (VRNA)
is a Sell
Is Verona Pharma PLC a Buy, Sell or Hold?
-
The current Verona Pharma PLC [VRNA] share price is $45.28. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
VRNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FINV Stock Price Chart
What is FinVolution Group's stock price today?
-
The FinVolution Group share price today is $6.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FINV is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $45.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
FINV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 57.64 | Buy |
| Chaikin Money Flow: | 310642 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.38 - 7) | Buy |
| Bollinger Bands (100): | (5.44 - 6.58) | Buy |
VRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.47 | Buy |
| Relative Strength Index (14 RSI): | 69.35 | Buy |
| Chaikin Money Flow: | 672029 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.1 - 41.82) | Buy |
| Bollinger Bands (100): | (26.7 - 38.58) | Buy |
FINV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.84 | Buy |
| 20-day SMA: | 6.81 | Buy |
| 50-day SMA: | 6.37 | Buy |
| 200-day SMA: | 5.48 | Buy |
| 8-day EMA: | 6.84 | Buy |
| 20-day EMA: | 6.74 | Buy |
| 50-day EMA: | 6.45 | Buy |
| 200-day EMA: | 5.69 | Buy |
VRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.71 | Buy |
| 20-day SMA: | 40.52 | Buy |
| 50-day SMA: | 37.79 | Buy |
| 200-day SMA: | 24.36 | Buy |
| 8-day EMA: | 42.01 | Buy |
| 20-day EMA: | 40.56 | Buy |
| 50-day EMA: | 37.61 | Buy |
| 200-day EMA: | 27.82 | Buy |
FinVolution Group Earnings Growth & FINV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.17 per share.
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.
FinVolution Group Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verona Pharma PLC Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||